Revvity ignites scientific breakthroughs at SLAS2025

Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging workflows for Revvity’s Harmony and Signals Image Artist software packages, the Phenologic.AI software leverages pre-trained deep-learning models to analyze brightfield images, providing an additional multiplexing channel and streamlined workflows for live cell analysis. This significant advancement expands the possibilities for understanding cellular behaviors and disease mechanisms. The Phenologic.AI offering provides scalable, efficient, and objective analysis and can be integrated with Revvity Signals Research Suite to provide more in-depth data analytics.

Complementing this launch, Revvity will also introduce other notable products, including the latest Harmony 5.3 software, which simplifies data management for high-content imaging and analysis, providing faster and more intuitive data handling.

Attendees can explore these technologies and more at Revvity’s booth (#1318), where over 40 products from its life sciences portfolio will be showcased. These include solutions for assay development, automation, cellular research, liquid handling, flow cytometry, and reagents, all designed to accelerate innovation and efficiency across drug discovery and development. Revvity’s strategy centers on supporting scientists in overcoming research challenges with transformative technologies.

SLAS is a great opportunity to showcase our most innovative technologies and celebrated brands. Our strategy and offerings are designed to support scientists in accelerating discoveries and expediting progress from basic research into clinical development.”

Kevin Quick, vice president of platforms, life sciences, Revvity

Key exhibits at SLAS2025

Revvity’s featured solutions include:

  • Assay development and automation: Custom automation solutions to boost throughput and reliability will be on display, including the explorer G3 integrated workstation.
  • Automated liquid handling: The Fontus liquid handler offers intuitive software, optimized protocols, and reformatting capabilities for streamlined productivity.
  • Cell imaging and AI: Advanced tools like the Opera Phenix Plus HCS system will be on display, alongside the Phenologic.AI offering.
  • Reagents portfolio: Including PhenoVue imaging reagents, BioLegend antibodies, and Dharmacon CRISPR screening libraries. Revvity Proprietary Information

For detailed information on the showcased innovations, scientific talks, and posters, visit booth #1318 or Revvity’s SLAS2025 events page.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Revvity. (2025, January 24). Revvity ignites scientific breakthroughs at SLAS2025. News-Medical. Retrieved on January 24, 2025 from https://www.news-medical.net/news/20250124/Revvity-ignites-scientific-breakthroughs-at-SLAS2025.aspx.

  • MLA

    Revvity. "Revvity ignites scientific breakthroughs at SLAS2025". News-Medical. 24 January 2025. <https://www.news-medical.net/news/20250124/Revvity-ignites-scientific-breakthroughs-at-SLAS2025.aspx>.

  • Chicago

    Revvity. "Revvity ignites scientific breakthroughs at SLAS2025". News-Medical. https://www.news-medical.net/news/20250124/Revvity-ignites-scientific-breakthroughs-at-SLAS2025.aspx. (accessed January 24, 2025).

  • Harvard

    Revvity. 2025. Revvity ignites scientific breakthroughs at SLAS2025. News-Medical, viewed 24 January 2025, https://www.news-medical.net/news/20250124/Revvity-ignites-scientific-breakthroughs-at-SLAS2025.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure